Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-017583
Filing Date
2013-03-18
Accepted
2013-03-18 19:12:54
Documents
1
Period of Report
2013-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd374592.html 4  
1 FORM 4 rrd374592.xml 4 14204
  Complete submission text file 0001181431-13-017583.txt   15534
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address
El-Hibri Fuad (Reporting) CIK: 0001380185 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 13699482